Our CSO, Maxime Feyeux, contributed to a roundtable entitled \u201cWhat breakthrough innovations to develop next-generation bioproduction factories ?\u201d organized by BPI France and Medicen in Paris on October 10th 2019, during the Innogeneration event.<\/span>
<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"https:\/\/youtu.be\/Fqn098sYBzc Our CSO, Maxime Feyeux, contributed to a roundtable entitled \u201cWhat breakthrough innovations to develop next-generation bioproduction factories ?\u201d organized by BPI France and Medicen in Paris on October 10th 2019, during the Innogeneration event.<\/p>\n","protected":false},"author":1,"featured_media":1232,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"video","meta":{"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[15],"tags":[],"aioseo_notices":[],"yoast_head":"\n
TreeFrog Therapeutics at BIG by BPIfrance - TreeFrog Therapeutics I iPS-derived cell therapies<\/title>\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\t\n\n\n